Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 1,501–1,525 of 7,816 matching trials · page 61 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
ED-LEAD: Emergency Departments Leading the Transformation of Alzheimer's and Dementia Care NCT06079203 Emergency Care Redesign (ECR); Nurse-led Telephonic Care (NLTC); Co... Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 19,200 | NYU Langone Health OTHER |
2026-03-02 |
|
Home Tele Rehabilitation Therapy for Vascular Dementia NCT06289569 Home telerehabilitation therapy Runs in: United States · 1 site |
NA other |
RECRUITING | 120 | The Methodist Hospital Research Institute OTHER |
2026-03-02 |
|
Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease NCT06484244 5 Sessions of Split-belt Treadmill-based Locomotor Adaptation Runs in: United States · 1 site |
NA other |
RECRUITING | 10 | Emory University OTHER |
2026-03-02 |
|
Cognitive Assessment Tools for Huntington's Disease. NCT06546488 Assessments Runs in: United States · 1 site |
NA other |
RECRUITING | 76 | Ohio State University OTHER |
2026-03-02 |
|
10-Year Survival After Acute Hip Fracture in Patients With Preclinical/Clinical Alzheimer Pathology NCT07443566 Runs in: Sweden · 1 site |
NA other |
COMPLETED | 404 | Bengt Nellgård OTHER |
2026-03-02 |
|
Language in Primary Progressive Aphasia NCT00537004 Runs in: United States · 1 site |
NA other |
RECRUITING | 500 | Northwestern University OTHER |
2026-02-27 |
|
Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab NCT04270175 Daratumumab SC; Pomalidomide; Dexamethasone Runs in: United States · 4 sites |
PHASE2 other |
ACTIVE_NOT_RECRUITING | 15 | Weill Medical College of Cornell University OTHER |
2026-02-27 |
|
Couples Lived Experience NCT04863495 Runs in: United States · 2 sites |
NA other |
COMPLETED | 544 | NYU Langone Health OTHER |
2026-02-27 |
|
An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease NCT05522387 XPro1595 Runs in: Australia · 4 sites |
PHASE2 other |
TERMINATED | 11 | Inmune Bio, Inc. INDUSTRY |
2026-02-27 |
|
Home-based tDCS in Frontotemporal Dementia or Alzheimer's Disease NCT05978804 Computerized Cognitive Training; Active tDCS (tDCS) on DLPFC Runs in: United States · 1 site |
NA other |
TERMINATED | 36 | Johns Hopkins University OTHER |
2026-02-27 |
|
HEARS-SLP: Providing SLP-Delivered Hearing Health Care to Individuals With Cognitive Impairment NCT06008782 HEARS-SLP device; HEARS-SLP program Runs in: United States · 1 site |
NA other |
COMPLETED | 77 | Johns Hopkins University OTHER |
2026-02-27 |
|
Improving Sleep and AD Biomarkers NCT06029894 Citicoline Supplement; Placebo Runs in: United States · 2 sites |
NA other |
COMPLETED | 100 | Emory University OTHER |
2026-02-27 |
|
Assessing the Effects of Cool Roofs on Indoor Environments and Health in Niue NCT06570993 Cool roof Runs in: Niue · 1 site |
NA other |
COMPLETED | 288 | Aditi Bunker OTHER |
2026-02-27 |
|
Assessing the Effects of Cool Roofs on Indoor Environments and Health NCT06579950 Cool roof Runs in: Burkina Faso; Fiji; India; Mexico; Niue · 5 sites |
NA other |
RECRUITING | 3,200 | Aditi Bunker OTHER |
2026-02-27 |
|
Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER) NCT07435467 collection of blood samples Runs in: Italy · 3 sites |
NA other |
RECRUITING | 400 | Istituto Nazionale di Ricovero e Cura per Anziani OTHER |
2026-02-27 |
|
Managing Aggression: Effectiveness of Model-Based Standardized Patient Simulation NCT07438340 Standardized Patient Simulation Based on the De-Escalation Model in... Runs in: Turkey (Türkiye) · 1 site |
NA other |
NOT_YET_RECRUITING | 56 | Yuksek Ihtisas University OTHER |
2026-02-27 |
|
The Sunnybrook Dementia Study NCT01800214 Runs in: Canada · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 1,800 | Sunnybrook Health Sciences Centre OTHER |
2026-02-25 |
|
A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease NCT05744401 AL002 Runs in: Argentina; Australia; Canada; Germany; Italy; Netherlands... · 54 sites |
PHASE2 other |
TERMINATED | 197 | Alector Inc. INDUSTRY |
2026-02-25 |
|
Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive Impairment NCT06041152 Psilocybin; Placebo Runs in: Canada · 1 site |
PHASE2 other |
ACTIVE_NOT_RECRUITING | 10 | Centre for Addiction and Mental Health OTHER |
2026-02-25 |
|
Under-Represented Communities Diagnosed With SCD or MCI Through Tele-Cog NCT06542458 Assessments; Neuroimaging volumetric measures; Biofluid samples Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 1,000 | Ohio State University OTHER |
2026-02-25 |
|
To Evaluate the Efficacy, Safety, and Tolerability of Dronabinol Oral Solution for Agitation in Patients With Alzheimer's Disease NCT07422311 Dronabinol Oral Solution; Placebo Control Runs in: Australia · 1 site |
PHASE2|PHASE3 other |
NOT_YET_RECRUITING | 140 | Benuvia Therapeutics Inc. INDUSTRY |
2026-02-25 |
|
Comparative Study of High Performance Low-Cost Optical Coherence Tomography (Stage 1B, 2 and 3) NCT07425106 retinal imaging with low-cost OCT-a/LCI device Runs in: United States · 1 site |
NA other |
ENROLLING_BY_INVITATION | 82 | Duke University OTHER |
2026-02-25 |
|
Effects of Pomegranate Seed Oil Supplementation in Patients With Advanced Dementia NCT07432763 Pomegranate Seed Oil Supplementation in Palliative Care Patients wi... Runs in: Greece · 1 site |
NA other |
COMPLETED | 18 | Panhellenic Federation of Alzheimer's Disease and Related Disorders OTHER |
2026-02-25 |
|
Pharmacological Enhancement of Glymphatic Function in Humans NCT07432997 Dexmedetomidine; Dexmedetomidine and Midodrine; Placebo Runs in: United States · 2 sites |
PHASE1|PHASE2 other |
COMPLETED | 31 | Applied Cognition INDUSTRY |
2026-02-25 |
|
German Dementia Registry NCT07433010 This is a registry. Runs in: Germany · 24 sites |
NA other |
RECRUITING | 5,000 | RWTH Aachen University OTHER |
2026-02-25 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial